{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
mafodotin
to a specific field?
Status:
Investigational
Source:
INN:moflerafusp alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:empasiprubart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:mozistobart zoratolimod [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03428022: Phase 3 Interventional Unknown status NSCLC
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02573324: Phase 3 Interventional Completed Glioblastoma
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03336606: Phase 1 Interventional Active, not recruiting Head and Neck Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03849651: Phase 2 Interventional Active, not recruiting Acute Lymphoblastic Leukemia (ALL)
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
USAN:DENINTUZUMAB [USAN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01786096: Phase 1 Interventional Completed Burkitt Lymphoma
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
